S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+metastatic breast cancer

被引：0
|
作者：
Toh, U. [1 ]
Iwakuma, N. [1 ]
Mishima, M. [1 ]
Furukawa, M. [1 ]
Fujii, T. [1 ]
Ogo, E. [2 ]
Nakagawa, S. [3 ]
Tanaka, M. [4 ]
Akagi, Y. [1 ]
机构：
[1] Kurume Univ, Sch Med, Surg, Kurume, Fukuoka 830, Japan
[2] Kurume Univ, Sch Med, Radiol, Kurume, Fukuoka 830, Japan
[3] Natl Hosp Org, Kyushu Med Ctr, Breast Surg, Fukuoka, Japan
[4] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70059-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P008
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [11] Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer
    Hiroya Takiuchi
    Gastric Cancer, 2009, 12 : 55 - 59
  • [12] Irinotecan (CPT-11) in pretreated metastatic colorectal cancer (CRC)
    Lara, MA
    Feliu, J
    Salinas, P
    Fernandez, Y
    Garcia-Giron, C
    ANNALS OF ONCOLOGY, 1998, 9 : 45 - 46
  • [13] Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study
    Kojima, Yasuyuki
    Yoshie, Reiko
    Kawamoto, Hisanori
    Shimo, Arata
    Uejima, Tomoko
    Iwatani, Tsuguo
    Motoyoshi, Ai
    Kanemaki, Yoshihide
    Boku, Narikazu
    Tsugawa, Koichiro
    ONCOLOGY, 2019, 96 (06) : 309 - 317
  • [14] Comparative effectiveness of trastuzumab emtansine versus lapatinib plus capecitabine for HER2+metastatic breast cancer
    Ramagopalan, Sreeram, V
    Pisoni, Riccardo
    Zenin, Aleksandr
    Rathore, Lokendra Singh
    Ray, Joshua
    Sammon, Cormac
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (07) : 595 - 602
  • [15] Phase I/II trial of ruxolitinib in combination with trastuzumab in HER2+metastatic breast cancer (MBC)
    Kalinsky, Kevin
    Lee, Shing
    Tiersten, Amy
    Makower, Della F.
    Cigler, Tessa
    Franks, Lauren
    Mundi, Prabhjot
    Chi, Dow-Chung
    Blumberg, Lauren
    Sender, Naomi
    Galazyn, Magdalena
    Hosi, Kristina
    Goel, Anupama
    Klein, Paula
    Andreopoulou, Eleni
    Sparano, Joseph
    Crew, Katherine D.
    Califano, Andrea
    Silva, Jose
    Hershman, Dawn L.
    CANCER RESEARCH, 2020, 80 (04)
  • [16] The association of centromere amplification and response to trastuzumab in HER2+metastatic breast cancer
    Andrieu, Charlotte
    Al-Sultan, Dalal
    Ivers, Laura
    Pina, Jose Javier Berenguer
    Skrobo, Darko
    Ballot, Josephine
    Eustace, Alex J.
    Gullo, Giuseppe
    Crown, John
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [17] Infusion related reactions in the phase 3 SOPHIA trial of margetuximab plus chemotherapy vs trastuzumab plus chemotherapy in patients with pretreated HER2+metastatic breast cancer
    Cortes, Javier
    Cardoso, Fatima
    Curigliano, Giuseppe
    Gradishar, William J.
    Im, Seock-Ah
    Rugo, Hope S.
    Bahadur, Shakeela W.
    Falcone, Alfredo
    Murillo, Serafin Morales
    Riseberg, David A.
    Musolino, Antonino
    Feinstein, Trevor M.
    Abreu, Miguel H.
    Im, Young-Hyuck
    Novik, Yelena
    Pluard, Timothy
    Salazar, Lupe G.
    Berardi, Rossana
    Pop, Viorela
    Hong, Shengyan
    Jacobs, Kenneth
    Rock, Edwin
    Pegram, Mark D.
    CANCER RESEARCH, 2021, 81 (04)
  • [18] An Evaluation of the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2+Metastatic Breast Cancer
    Esteva, F. J.
    Franco, S. X.
    Hagan, M. K.
    Somer, R. A.
    Dombroski, C. S.
    Florance, A. M.
    Turner, S. J.
    Stein, S.
    Perez, A.
    CANCER RESEARCH, 2009, 69 (24) : 793S - 793S
  • [19] Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)
    Fujii, Takaaki
    Horiguchi, Jun
    Yanagita, Yasuhiro
    Koibuchi, Yukio
    Ikeda, Fumihiro
    Uchida, Nobuyuki
    Kimura, Morihiko
    ANTICANCER RESEARCH, 2018, 38 (02) : 905 - 909
  • [20] A Phase I Study of Capecitabine Combined with CPT-11 in Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
    Kashiwaba, Masahiro
    Inaba, Toru
    Komatsu, Hideaki
    Ishida, Kazushige
    Kawagishi, Ryoko
    Matsui, Yusuke
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Wakabayashi, Go
    ONCOLOGY, 2014, 86 (04) : 206 - 211
12345